Clinical Oncology – Previous Examination Papers
4.
Patients with terminal malignancy frequently suffer from nausea and vomiting. Discuss the aetiology and
how these symptoms may be alleviated.
5.
What is the rationale and role for the use of Positron Emission Tomography in the management of
malignant disease?
6.
Evaluate the follow up of patients previously treated for cure of cancer.
August 2002
1.
Discuss the potential and limitations of screening in the control of bowel cancer.
2.
How would you assess the quality of life in patients treated palliatively for malignant disease?
3.
Discuss the management of Ductal Carcinoma-in-Situ of the breast.
4.
Evaluate the current role of chemotherapy in the treatment of head and neck cancer.
5.
Discuss the causes and management of dyspnoea in patients with malignant disease.
6.
Evaluate the risks of treatment induced malignancy in patients treated for cure and explain how you would
present these risks to patients and their carers.
February 2002
1.
Discuss the management of lymph nodes in patients with malignant melanoma.
2.
A 35 year old woman is 16 weeks pregnant with her first child. She is found to have a 2cm infiltrating
ductal carcinoma of the right breast Discuss her treatment options.
3.
Discuss the diagnosis and management of depression in patients with advanced malignant disease.
4.
Evaluate the role of high dose chemotherapy with autografting in the management of malignant disease.
5.
Evaluate the utilization of complementary and alternative medicine in patients with malignant disease.
6.
Discuss the potential of familial cancer clinics and genetic counselling and testing.
August 2001
1.
A 35 year old man is referred following right inguinal orchidectomy for a classical marker negative
seminoma. Staging investigations are clear. Discuss your recommendations.
2.
Discuss the application of evidence based medicine principles to oncological practice.
3.
Evaluate the contribution of chemotherapy to the management of Head and Neck cancer.
4.
Discuss your approach to the management of nausea and vomiting in patients with advanced malignant
disease.
5.
A 45 year old woman presents with inflammatory breast cancer. Staging shows no metastatic disease.
Discuss your management.
6.
A fit asymptomatic man aged 60 is found to have a liver enlargement 4cm below the costal margin. CT
scanning shows multiple metastases and fine needle aspiration biopsy shows adenocarcinoma. How
would you manage this man?
February 2001
1
Discuss the role of aromatase inhibitors in the management of breast cancer.
2
Discuss the management of depression in patients with malignant disease.
3
Briefly evaluate the causes of breathlessness in patients with malignant disease and describe
techniques for relieving it.
4
A patient with pelvic malignant disease develops renal failure due to ureteric compression. What
factors would determine your management?
5
Evaluate the evidence available to guide the multidisciplinary breast cancer team in the
management of the axilla in patients with breast cancer.
6
Discuss the development of second malignancies in patients treated for cure and how you would
present these risks to the patient and their family.
August 2000
1.
Discuss the rationale and current status of synchronous chemoradiation in the management of malignant
disease.
2.
Discuss the use of drugs, other than anti-cancer agents, in the management of pain in malignant disease.
3.
Discuss the various non-surgical modalities that may be of benefit for treatment of metastatic melanoma.
4.
Discuss the value and limitations of serum tumour markers in the management of malignant disease.
5.
Discuss screening for the early detection of colorectal carcinoma.
6.
Describe how you would set up an oncology database for a new oncology centre.
February 2000
1.
Two years ago a 53 year old woman had a right modified radical mastectomy for a T2 N1 infiltrating
ductal carcinoma of the breast. This was followed by a course of anthracycline containing chemotherapy.
She now presents with a biopsy proven nodal metastasis in the right supraclavicular fossa. Staging
investigations do not demonstrate any other disease spread. Discuss your management.
2.
Discuss the role of Positron Emission Tomography in the management of malignant disease.
3.
Discuss the palliative care of patients with symptomatic intrathoracic malignancy.
